These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 4473060)

  • 1. Abnormalities in tryptophan metabolites in schizophrenia.
    Frohman CE; Caldwell DF; Gottlieb JS
    Psychopharmacol Bull; 1974 Jul; 10(3):56-7. PubMed ID: 4473060
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies in schizophrenia, V. Disturbances of protein and tryptophan metabolism and toxicity of urine.
    FLEISCHHACKER HH; LANCASTER JB; WHEELER AP
    J Ment Sci; 1959 Apr; 105(439):313-25. PubMed ID: 13665293
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical and physiopathological bases of the study of tryptophan metabolism in schizophrenia].
    Dogaru C; Grecu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(2):141-50. PubMed ID: 6238390
    [No Abstract]   [Full Text] [Related]  

  • 4. Schizophrenia, a disorder of tryptophan metabolism.
    Gilka L
    Acta Psychiatr Scand Suppl; 1975; 258():1-83. PubMed ID: 1056684
    [No Abstract]   [Full Text] [Related]  

  • 5. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
    Miller CL; Llenos IC; Cwik M; Walkup J; Weis S
    Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tryptophan and its metabolism in schizophrenia].
    Szafranek J; Szafranek K
    Psychiatr Pol; 1970; 4(5):585-8. PubMed ID: 4921675
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tryptophan metabolism in schizophrenia].
    Rosengarten H; Marcjan K; Cwiertnia T; Stencka K; Rybus G
    Psychiatr Pol; 1970; 4(3):253-9. PubMed ID: 5459694
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disturbances of tryptophan metabolism during methionine and nialamide administration in chronic schizophrenic patients].
    Rosengarten H; Stencka K; Kowalska K; Wardaszko-Lyskowska H; Szemis A; Wlosińska I; Krzyzowski J; Jus A
    Psychiatr Pol; 1970; 4(3):261-8. PubMed ID: 5459695
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and clinical changes resulting from administration of marsilid and tryptophan to schizophrenic patients; the clinical aspects.
    LAUER JW
    J Clin Exp Psychopathol; 1958; 19(2, Suppl. 1):110-3. PubMed ID: 13549575
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical and clinical changes resulting from administration of marsilid and tryptophan to schizophrenic patients; biochemical aspects.
    ZELLER EA
    J Clin Exp Psychopathol; 1958; 19(2, Suppl. 1):106-9. PubMed ID: 13549574
    [No Abstract]   [Full Text] [Related]  

  • 11. Excretion of indoleamines in schizophrenia.
    Bueno JR; Himwich HE
    Int J Neurol; 1967; 6(1):65-76. PubMed ID: 5622712
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical aspects of schizophrenia.
    Stewart BM
    Am J Nurs; 1975 Dec; 75(12):2176-9. PubMed ID: 53014
    [No Abstract]   [Full Text] [Related]  

  • 13. Schizophrenia--new concepts.
    Gottlieb JS; Frohman CE; Harmison CR
    South Med J; 1971 Jun; 64(6):743-9. PubMed ID: 4103649
    [No Abstract]   [Full Text] [Related]  

  • 14. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
    Barry S; Clarke G; Scully P; Dinan TG
    J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic and psychiatric diseases.
    PRICE JM; BROWN RR; PETERS HA
    Neurology; 1959 Jul; 9(7):456-68. PubMed ID: 13666928
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical study of a schizophreniac].
    Caridroit M; Duc-Aublet F; Testegute T; Miens C; Fontan M; Caridroit M
    Lille Med; 1973 Dec; 18(10):1186-201. PubMed ID: 4794244
    [No Abstract]   [Full Text] [Related]  

  • 17. [Carcinogenic metabolites of tryptophan].
    Zasypka AT
    Vopr Onkol; 1969; 15(7):108-18. PubMed ID: 4898352
    [No Abstract]   [Full Text] [Related]  

  • 18. [The interaction of tryptophan, histidine and glycine incorporating into rat organ proteins in in vitro and in vivo experiments].
    Gulyi MF; Daniliuk TP
    Ukr Biokhim Zh; 1972; 44(2):225-8. PubMed ID: 4661068
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.
    Kim YK; Myint AM; Verkerk R; Scharpe S; Steinbusch H; Leonard B
    Neuropsychobiology; 2009; 59(2):123-9. PubMed ID: 19390223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo.
    Bauer TM; Jiga LP; Chuang JJ; Randazzo M; Opelz G; Terness P
    Transpl Int; 2005 Jan; 18(1):95-100. PubMed ID: 15612990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.